company background image
NOVT logo

Novanta NasdaqGS:NOVT Rapport sur les actions

Dernier prix

US$181.16

Capitalisation boursière

US$6.5b

7D

5.7%

1Y

20.0%

Mise à jour

19 Aug, 2024

Données

Finances de l'entreprise +

Novanta Inc.

NasdaqGS:NOVT Rapport sur les actions

Capitalisation boursière : US$6.5b

La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !

NOVT Aperçu des actions

Novanta Inc. et ses filiales proposent des services de médecine et de fabrication de précision, des solutions médicales et des solutions de robotique et d'automatisation aux États-Unis et dans le monde entier.

NOVT analyse fondamentale
Score flocon de neige
Évaluation1/6
Croissance future4/6
Performances passées2/6
Santé financière3/6
Dividendes0/6

Novanta Inc. Concurrents

Historique des prix et performances

Résumé des plus hauts, des changements et des baisses de prix pour Novanta
Historique des cours de bourse
Prix actuel de l'actionUS$181.16
Plus haut sur 52 semainesUS$187.12
Plus bas sur 52 semainesUS$111.20
Bêta1.31
1Variation sur 1 mois5.03%
Variation sur 3 mois9.26%
Variation sur 1 an19.99%
3Variation sur 3 ans23.54%
Variation sur 5 ans153.37%
Évolution depuis l'introduction en bourse1,036.68%

Nouvelles et mises à jour récentes

Novanta Inc.'s (NASDAQ:NOVT) Intrinsic Value Is Potentially 21% Below Its Share Price

Aug 02
Novanta Inc.'s (NASDAQ:NOVT) Intrinsic Value Is Potentially 21% Below Its Share Price

Recent updates

Novanta Inc.'s (NASDAQ:NOVT) Intrinsic Value Is Potentially 21% Below Its Share Price

Aug 02
Novanta Inc.'s (NASDAQ:NOVT) Intrinsic Value Is Potentially 21% Below Its Share Price

Novanta (NASDAQ:NOVT) Might Be Having Difficulty Using Its Capital Effectively

Jun 22
Novanta (NASDAQ:NOVT) Might Be Having Difficulty Using Its Capital Effectively

Does Novanta (NASDAQ:NOVT) Have A Healthy Balance Sheet?

May 30
Does Novanta (NASDAQ:NOVT) Have A Healthy Balance Sheet?

Investors Still Waiting For A Pull Back In Novanta Inc. (NASDAQ:NOVT)

May 08
Investors Still Waiting For A Pull Back In Novanta Inc. (NASDAQ:NOVT)

Novanta (NASDAQ:NOVT) Has Some Way To Go To Become A Multi-Bagger

Feb 24
Novanta (NASDAQ:NOVT) Has Some Way To Go To Become A Multi-Bagger

Does Novanta (NASDAQ:NOVT) Have A Healthy Balance Sheet?

Feb 05
Does Novanta (NASDAQ:NOVT) Have A Healthy Balance Sheet?

Getting In Cheap On Novanta Inc. (NASDAQ:NOVT) Is Unlikely

Dec 29
Getting In Cheap On Novanta Inc. (NASDAQ:NOVT) Is Unlikely

Why Novanta Inc. (NASDAQ:NOVT) Could Be Worth Watching

Nov 20
Why Novanta Inc. (NASDAQ:NOVT) Could Be Worth Watching

Here's Why We Think Novanta (NASDAQ:NOVT) Is Well Worth Watching

Nov 01
Here's Why We Think Novanta (NASDAQ:NOVT) Is Well Worth Watching

Does This Valuation Of Novanta Inc. (NASDAQ:NOVT) Imply Investors Are Overpaying?

Oct 19
Does This Valuation Of Novanta Inc. (NASDAQ:NOVT) Imply Investors Are Overpaying?

Novanta (NASDAQ:NOVT) Seems To Use Debt Quite Sensibly

Sep 21
Novanta (NASDAQ:NOVT) Seems To Use Debt Quite Sensibly

Return Trends At Novanta (NASDAQ:NOVT) Aren't Appealing

Sep 06
Return Trends At Novanta (NASDAQ:NOVT) Aren't Appealing

What Does Novanta Inc.'s (NASDAQ:NOVT) Share Price Indicate?

Aug 19
What Does Novanta Inc.'s (NASDAQ:NOVT) Share Price Indicate?

Here's Why We Think Novanta (NASDAQ:NOVT) Is Well Worth Watching

Jul 16
Here's Why We Think Novanta (NASDAQ:NOVT) Is Well Worth Watching

Slowing Rates Of Return At Novanta (NASDAQ:NOVT) Leave Little Room For Excitement

Jun 06
Slowing Rates Of Return At Novanta (NASDAQ:NOVT) Leave Little Room For Excitement

These 4 Measures Indicate That Novanta (NASDAQ:NOVT) Is Using Debt Reasonably Well

May 16
These 4 Measures Indicate That Novanta (NASDAQ:NOVT) Is Using Debt Reasonably Well

Should You Investigate Novanta Inc. (NASDAQ:NOVT) At US$156?

Apr 13
Should You Investigate Novanta Inc. (NASDAQ:NOVT) At US$156?

Here's Why We Think Novanta (NASDAQ:NOVT) Is Well Worth Watching

Mar 29
Here's Why We Think Novanta (NASDAQ:NOVT) Is Well Worth Watching

Investors Met With Slowing Returns on Capital At Novanta (NASDAQ:NOVT)

Feb 27
Investors Met With Slowing Returns on Capital At Novanta (NASDAQ:NOVT)

These 4 Measures Indicate That Novanta (NASDAQ:NOVT) Is Using Debt Safely

Feb 12
These 4 Measures Indicate That Novanta (NASDAQ:NOVT) Is Using Debt Safely

Is Novanta Inc. (NASDAQ:NOVT) Potentially Undervalued?

Jan 12
Is Novanta Inc. (NASDAQ:NOVT) Potentially Undervalued?

We Ran A Stock Scan For Earnings Growth And Novanta (NASDAQ:NOVT) Passed With Ease

Dec 28
We Ran A Stock Scan For Earnings Growth And Novanta (NASDAQ:NOVT) Passed With Ease

Is Novanta (NASDAQ:NOVT) Using Too Much Debt?

Nov 02
Is Novanta (NASDAQ:NOVT) Using Too Much Debt?

What Does Novanta Inc.'s (NASDAQ:NOVT) Share Price Indicate?

Oct 03
What Does Novanta Inc.'s (NASDAQ:NOVT) Share Price Indicate?

With EPS Growth And More, Novanta (NASDAQ:NOVT) Makes An Interesting Case

Sep 19
With EPS Growth And More, Novanta (NASDAQ:NOVT) Makes An Interesting Case

Novanta Inc. (NASDAQ:NOVT) Shares Could Be 31% Above Their Intrinsic Value Estimate

Aug 23
Novanta Inc. (NASDAQ:NOVT) Shares Could Be 31% Above Their Intrinsic Value Estimate

Novanta Non-GAAP EPS of $0.78 beats by $0.06, revenue of $215.34M beats by $6.27M, raises FY guidance

Aug 09

Novanta (NASDAQ:NOVT) Could Easily Take On More Debt

Aug 03
Novanta (NASDAQ:NOVT) Could Easily Take On More Debt

Here's What To Make Of Novanta's (NASDAQ:NOVT) Decelerating Rates Of Return

Jul 11
Here's What To Make Of Novanta's (NASDAQ:NOVT) Decelerating Rates Of Return

At US$124, Is Novanta Inc. (NASDAQ:NOVT) Worth Looking At Closely?

Jun 09
At US$124, Is Novanta Inc. (NASDAQ:NOVT) Worth Looking At Closely?

Calculating The Fair Value Of Novanta Inc. (NASDAQ:NOVT)

May 10
Calculating The Fair Value Of Novanta Inc. (NASDAQ:NOVT)

Novanta (NASDAQ:NOVT) Seems To Use Debt Rather Sparingly

Apr 22
Novanta (NASDAQ:NOVT) Seems To Use Debt Rather Sparingly

Returns On Capital At Novanta (NASDAQ:NOVT) Paint A Concerning Picture

Apr 03
Returns On Capital At Novanta (NASDAQ:NOVT) Paint A Concerning Picture

Rendement pour les actionnaires

NOVTUS ElectronicUS Marché
7D5.7%5.9%4.9%
1Y20.0%21.3%25.6%

Rendement vs Industrie: NOVT correspondait au secteur US Electronic qui a rapporté 20.2 % au cours de l'année écoulée.

Rendement vs marché: NOVT underperformed the US Market which returned 24.7% over the past year.

Volatilité des prix

Is NOVT's price volatile compared to industry and market?
NOVT volatility
NOVT Average Weekly Movement5.7%
Electronic Industry Average Movement7.3%
Market Average Movement6.3%
10% most volatile stocks in US Market15.0%
10% least volatile stocks in US Market3.2%

Cours de l'action stable: NOVT has not had significant price volatility in the past 3 months.

Volatilité au fil du temps: NOVT's weekly volatility (6%) has been stable over the past year.

À propos de l'entreprise

FondéeSalariésPDGSite web
19682,900Matthijs Glastrawww.novanta.com

Novanta Inc. et ses filiales proposent des services de médecine et de fabrication de précision, des solutions médicales et des solutions de robotique et d'automatisation aux États-Unis et dans le monde entier. La société opère à travers trois segments : Médecine et fabrication de précision, Solutions médicales et Robotique et automatisation. Le secteur de la médecine et de la fabrication de précision propose des solutions photoniques, notamment des produits de balayage laser, de délivrance de faisceaux, de laser CO2, de laser à semi-conducteurs, de laser ultrarapide et de moteur optique à lumière, destinés à des applications photoniques pour le traitement industriel, la métrologie, l'imagerie médicale et des sciences de la vie, le séquençage de l'ADN et les procédures médicales au laser.

Novanta Inc. Résumé des fondamentaux

Comment les bénéfices et les revenus de Novanta se comparent-ils à sa capitalisation boursière ?
NOVT statistiques fondamentales
Capitalisation boursièreUS$6.47b
Bénéfices(TTM)US$62.17m
Recettes(TTM)US$899.85m

104.6x

Ratio P/E

7.2x

Ratio P/S

Le site NOVT est-il surévalué ?

Voir Juste valeur et analyse de l'évaluation

Bénéfices et recettes

Principales statistiques de rentabilité tirées du dernier rapport sur les bénéfices (TTM)
NOVT compte de résultat (TTM)
RecettesUS$899.85m
Coût des recettesUS$502.60m
Marge bruteUS$397.25m
Autres dépensesUS$335.09m
Les revenusUS$62.17m

Derniers bénéfices déclarés

Jun 28, 2024

Prochaine date de publication des résultats

s/o

Résultat par action (EPS)1.73
Marge brute44.15%
Marge bénéficiaire nette6.91%
Ratio dettes/capitaux propres68.7%

Quelles ont été les performances à long terme de NOVT?

Voir les performances historiques et les comparaisons